The United Kingdom’s National Health Service (NHS) is embarking on an ambitious gene-sequencing project with 11 genomics institutions in England. The objective is to find targeted treatments for a spectrum of illnesses.

The chief executive officer of Park Avenue hedge fund Third Point, is set to donate $15 million to Mount Sinai Hospital and the Icahn School of Medicine in New York City for a new research institute devoted to studying Alzheimer’s disease.

Fluorescent lights depict the electrical firing of neurons in the brain in this striking video demonstration reported by Bloomberg. The technology was developed by Adam E. Cohen, PhD, a Harvard neuroscientist and professor of chemical biology and physics.

Every week, Molecular Imaging brings hard-hitting neuroimaging research to light, but today we are highlighting the unorthodox work of one neuroscientist—his paintings, in fact, which depict the microstructure of the brain.

Definiens, the global leader in Tissue Phenomics® for oncology diagnostics, today announced the newest version of its leading image analysis software for quantitative digital pathology, Tissue Studio 4.0. The new release provides greater flexibility, more accurate and consistent results, and the ability to use any chromogen for single and dual stain immunohistochemistry (IHC) quantification.

Genetic research from John Hopkins and the University of Alabama Birmingham are providing a road map of inflammation linked to autism thanks to a fleet of tissue samples from 72 autistic and healthy brains. Analyses of these tissues showed microglial cells in perpetual hyperdrive, which translates into neuro-inflammation.

Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that it has reached the planned enrollment of 1,200 patients in the PROSPECT Phase 3 clinical study of its targeted active immunotherapy candidate, PROSTVAC®, in the treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Patients were enrolled at 214 sites in 15 countries.

One of the biggest challenges in medicine today is getting effective diagnostic and therapeutic drugs through the regulatory process unscathed. Judit Rius, the U.S. manager and legal policy adviser for Doctors Without Borders has words of wisdom to share about how to improve FDA reviews and incentives for the development of treatments for much needed drugs, including those for neglected tropical diseases.